Literature DB >> 18184712

Differential requirements for T cells in viruslike particle- and rotavirus-induced protective immunity.

Sarah E Blutt1, Kelly L Warfield, Mary K Estes, Margaret E Conner.   

Abstract

Correlates of protection from rotavirus infection are controversial. We compared the roles of B and T lymphocytes in protective immunity induced either by intranasally administered nonreplicating viruslike particles or inactivated virus or by orally administered murine rotavirus. We found that protection induced by nonreplicating vaccines requires CD4(+) T cells and CD40/CD40L. In contrast, T cells were not required for short-term protective immunity induced by infection, but both T-cell-dependent and -independent mechanisms contributed to long-term maintenance of protection. Our findings indicate that more than one marker of protective immunity exists and that these markers depend on the vaccine that is administered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184712      PMCID: PMC2259010          DOI: 10.1128/JVI.01727-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice.

Authors:  Andrea Bertolotti-Ciarlet; Max Ciarlet; Sue E Crawford; Margaret E Conner; Mary K Estes
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

2.  Rotavirus virus-like particles administered mucosally induce protective immunity.

Authors:  C M O'Neal; S E Crawford; M K Estes; M E Conner
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  CD8+ T cells can mediate almost complete short-term and partial long-term immunity to rotavirus in mice.

Authors:  M A Franco; C Tin; H B Greenberg
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

4.  Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group.

Authors:  R L Ward; D R Knowlton; E T Zito; B L Davidson; R Rappaport; M E Mack
Journal:  J Infect Dis       Date:  1997-09       Impact factor: 5.226

5.  Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells.

Authors:  S E Crawford; M Labbé; J Cohen; M H Burroughs; Y J Zhou; M K Estes
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  Immunity to rotavirus in T cell deficient mice.

Authors:  M A Franco; H B Greenberg
Journal:  Virology       Date:  1997-11-24       Impact factor: 3.616

7.  Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

Authors:  N Feng; J W Burns; L Bracy; H B Greenberg
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice.

Authors:  M M McNeal; K S Barone; M N Rae; R L Ward
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

9.  Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice.

Authors:  M A Franco; H B Greenberg
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Global illness and deaths caused by rotavirus disease in children.

Authors:  Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more
  6 in total

Review 1.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

2.  B-Cell-Deficient and CD8 T-Cell-Depleted Gnotobiotic Pigs for the Study of Human Rotavirus Vaccine-Induced Protective Immune Responses.

Authors:  Ke Wen; Tammy Bui; Mariah Weiss; Guohua Li; Jacob Kocher; Xingdong Yang; Peter M Jobst; Todd Vaught; Jagdeece Ramsoondar; Suyapa Ball; Sherrie Clark-Deener; David Ayares; Lijuan Yuan
Journal:  Viral Immunol       Date:  2016-01-29       Impact factor: 2.257

3.  A gastrointestinal rotavirus infection mouse model for immune modulation studies.

Authors:  Karen Knipping; Monica M McNeal; Annelies Crienen; Geert van Amerongen; Johan Garssen; Belinda Van't Land
Journal:  Virol J       Date:  2011-03-08       Impact factor: 4.099

4.  The human intestinal IgA response; burning questions.

Authors:  Jo Spencer; Linda S Klavinskis; Louise D Fraser
Journal:  Front Immunol       Date:  2012-05-11       Impact factor: 7.561

5.  Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.

Authors:  Kirsi Tamminen; Suvi Lappalainen; Leena Huhti; Timo Vesikari; Vesna Blazevic
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

Review 6.  The gastrointestinal frontier: IgA and viruses.

Authors:  Sarah E Blutt; Margaret E Conner
Journal:  Front Immunol       Date:  2013-11-28       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.